JP2011505864A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505864A5 JP2011505864A5 JP2010538844A JP2010538844A JP2011505864A5 JP 2011505864 A5 JP2011505864 A5 JP 2011505864A5 JP 2010538844 A JP2010538844 A JP 2010538844A JP 2010538844 A JP2010538844 A JP 2010538844A JP 2011505864 A5 JP2011505864 A5 JP 2011505864A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- nucleic acid
- host cell
- vector
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000000935 antidepressant agent Substances 0.000 claims 1
- 229940005513 antidepressants Drugs 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 208000020016 psychiatric disease Diseases 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291602A EP2077278A1 (fr) | 2007-12-21 | 2007-12-21 | Peptide dérivé du récepteur 3 de la neurotensine et utilisation dans le traitemement de maladies psychiatriques |
| EP07291602.6 | 2007-12-21 | ||
| PCT/FR2008/001784 WO2009103898A1 (fr) | 2007-12-21 | 2008-12-18 | Peptide derive du recepteur 3 de la neurotensine et utilisation dans le traitement de maladies psychiatriques |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011505864A JP2011505864A (ja) | 2011-03-03 |
| JP2011505864A5 true JP2011505864A5 (enExample) | 2012-02-16 |
| JP5487117B2 JP5487117B2 (ja) | 2014-05-07 |
Family
ID=39304741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010538844A Active JP5487117B2 (ja) | 2007-12-21 | 2008-12-18 | ニューロテンシン受容体３に由来するペプチドおよび精神疾患の治療におけるその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8252748B2 (enExample) |
| EP (2) | EP2077278A1 (enExample) |
| JP (1) | JP5487117B2 (enExample) |
| AT (1) | ATE535543T1 (enExample) |
| CA (1) | CA2709907C (enExample) |
| ES (1) | ES2377489T3 (enExample) |
| WO (1) | WO2009103898A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2077278A1 (fr) | 2007-12-21 | 2009-07-08 | Centre National de la Recherche Scientifique (CNRS) | Peptide dérivé du récepteur 3 de la neurotensine et utilisation dans le traitemement de maladies psychiatriques |
| JP6640725B2 (ja) * | 2014-01-27 | 2020-02-05 | セントレ ナショナル デ ラ レチャーチェ シャーティフィック | ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す |
| CN108473541B (zh) * | 2015-11-24 | 2023-05-12 | 特拉斯福特普拉斯公司 | 通过受体介导的化学疗法治疗癌症的肽化合物和肽缀合物 |
| FR3057267A1 (fr) | 2016-10-11 | 2018-04-13 | Centre National De La Recherche Scientifique - Cnrs - | Procede de diagnostic/determination de l'efficacite de traitement de la depression |
| FR3057266B1 (fr) * | 2016-10-11 | 2021-05-21 | Centre Nat Rech Scient | Peptides derives du propeptide ntsr3 et leur utilisation dans le traitement de la depression |
| CN114555808A (zh) * | 2019-10-22 | 2022-05-27 | 吉尼松公司 | 嵌合多肽及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002511233A (ja) * | 1998-01-27 | 2002-04-16 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Ｔｒｅｋ１様の２孔カリウムチャネル |
| ATE545429T1 (de) * | 2002-12-20 | 2012-03-15 | Lundbeck & Co As H | Modulation der neurotrophinaktivität;screeningsverfahren |
| EP2077278A1 (fr) | 2007-12-21 | 2009-07-08 | Centre National de la Recherche Scientifique (CNRS) | Peptide dérivé du récepteur 3 de la neurotensine et utilisation dans le traitemement de maladies psychiatriques |
-
2007
- 2007-12-21 EP EP07291602A patent/EP2077278A1/fr not_active Withdrawn
-
2008
- 2008-12-18 US US12/809,884 patent/US8252748B2/en active Active
- 2008-12-18 JP JP2010538844A patent/JP5487117B2/ja active Active
- 2008-12-18 AT AT08872504T patent/ATE535543T1/de active
- 2008-12-18 WO PCT/FR2008/001784 patent/WO2009103898A1/fr not_active Ceased
- 2008-12-18 EP EP08872504A patent/EP2229408B1/fr active Active
- 2008-12-18 CA CA2709907A patent/CA2709907C/fr active Active
- 2008-12-18 ES ES08872504T patent/ES2377489T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012095652A5 (enExample) | ||
| JP2011511805A5 (enExample) | ||
| NZ590466A (en) | Treatment of inflammatory diseases with mammal beta defensins | |
| JP2010539988A5 (enExample) | ||
| JP2009225798A5 (enExample) | ||
| BR112014007469A2 (pt) | arcabouços de proteína com base em repetição de fibronectina tipo iii com superfícies de ligação alternativas | |
| IL260117A (en) | Use of placental cells to treat diseases, syndromes or conditions of the lungs | |
| JP2010534684A5 (enExample) | ||
| JP2011528332A5 (enExample) | ||
| JP2012500004A5 (enExample) | ||
| JP2011062217A5 (enExample) | ||
| JP2009542812A5 (enExample) | ||
| JP2012034696A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| FI3581650T3 (fi) | IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi | |
| JP2011500073A5 (enExample) | ||
| JP2013500720A5 (enExample) | ||
| JP2012503478A5 (enExample) | ||
| WO2009132656A3 (en) | Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin | |
| JP2010500717A5 (enExample) | ||
| NO20084488L (no) | Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith | |
| WO2013056049A3 (en) | Tubular prostheses | |
| JP2011152135A5 (enExample) | ||
| JP2013523718A5 (enExample) | ||
| WO2009138762A3 (en) | Therapeutic use of peptides |